19/03/2017

Argentine hemorrhagic fever vaccine effective against tumors

Scientists are a step closer to discovering a vaccine that works on tumors. Researchers from the Medical Faculty at Duisburg-Essen University (UDE) and the German Cancer Consortium (DKTK) have…

19/03/2017

DKTK Tübingen: Launch of leukemia treatment trial with new antibody

Acute myeloid leukemia (AML) can often be successfully repressed using the treatments currently available. However, in most cases, not all the cancer cells are eliminated and the disease often…

09/03/2017

Feuerwerk der guten Laune – großer Abschiedsbahnhof für Carsten Köhler

Carsten Köhler verlässt das DKTK und es ist, als verlören alle einen guten Bekannten. Sechs Jahre lang managte der Ökonom entschieden den Standort Berlin und versprühte standortübergreifend seinen…

06/03/2017

DKTK Freiburg: Physicists simplify production of hypersensitive contrast agent for cancer diagnostics

To make even the smallest tumor clusters and other pathological metabolic processes visible with the help of magnetic resonance imaging (MRI): Physicists from the German Cancer Consortium (DKTK) at…

06/03/2017

Martina Schüssler-Lenz elected as new chair of Committee for Advanced Therapies

At its February meeting, the European Medicines Agency’s (EMA) Committee for Advanced Therapies (CAT) elected Dr Martina Schüssler-Lenz as its new chair, for a three-year mandate. She follows…

03/03/2017

Guido Reifenberger wins German Cancer Award 2017

On 3 March, Prof. Guido Reifenberger from Düsseldorf University, who coordinates the DKTK’s Molecular Diagnostics, Early Detection and Biomarker Development research program, was presented with the…

13/02/2017

DKTK Dresden: 100 three-minute brainwaves – Cläre von Neubeck presents at Science Match

Engineers from Saxony presented new developments at the Future Technologies Science Match in Dresden, an event organized by the Free State of Saxony and the Tagesspiegel newspaper.

08/02/2017

DKTK Berlin: The Variety of the Tumor in 3D

During its formation, every tumor receives a specific genetic profile, which can be utilized for personalized cancer therapy. But even within one tumor, various regions can develop which have distinct…

07/02/2017

DKTK Berlin: Prof. Schulte wins the Dr. Maresch-Klingelhöffer Research Prize 2016

On 24 January, Prof. Johannes H. Schulte was presented with the Dr. Maresch-Klingelhöffer Research Prize by the Frankfurter Stiftung für krebskranke Kinder, a German childhood cancer foundation, for…

05/02/2017

DKTK Essen/Düsseldorf site symposium: Cancer research for patients

Developing clinically relevant laboratory models to shorten the journey from research to application was just one of the topics relating to clinically oriented cancer research presented at the site…

20/01/2017

Announces Fellow's Appointment at the German Cancer Consortium (DKTK) and the publication of her research in Nature Method

After working for four years at Stanford Medical School as a post-doctoral fellow in the genetics laboratory of Monte Winslow, Ph.D., Barbara Grüner has received an appointment of the German Cancer…

18/01/2017

DKTK Freiburg: Richtzenhain Prize 2016 - Better treatment for acute leukemia

Nikolas von Bubnoff and Robert Zeiser are physicians in the German Cancer Consortium (DKTK) at Freiburg University Hospital. They have produced research that has helped improve the treatment of acute…

12/01/2017

Cutting-Edge Research in Germany's Far West

New cancer research findings need to reach patients as quickly as possible. It was to achieve this aim that the DKFZ joined forces with research institutes and clinics at eight locations across…

04/01/2017

Interview with Michael Baumann: “It won’t work without collaborative partnerships”

Prof. Michael Baumann has been Scientific Director of the German Cancer Research Center (DKFZ) and Spokesman for the German Cancer Consortium since November 1. Before that, he worked in Dresden for 20…

19/12/2016

DKTK Heidelberg: Kidnapped enhancer activates cancer gene

The DNA of cancer cells is different from healthy cells. Often, genes or entire gene regions are deleted or duplicated. Due to such structural mutations, cancer-releasing genes can enter the vicinity…

01/12/2016

€2.5 million for developing a novel cancer immunotherapy

Scientists from the German Cancer Consortium (DKTK) at Tübingen University Hospital have developed a promising bispecific antibody for use in immunotherapy of prostate cancer and so-called squamous…

01/12/2016

Essen Physicians Receive Prize for Best Studies on Carcinogenesis and Cancer Treatment

Two scientists of the German Cancer Consortium (DKTK) have received the highest award by the Oncology in Internal Medicine Working Group (AIO) of the German Cancer Society. The physicians Wilfried…

24/11/2016

Prof. Martin Schuler joins the board of the Oncology in Internal Medicine Working Group (AIO) within the German Cancer Society

In November, Prof. Martin Schuler, Director of Internal Medicine (tumor research) and spokesman for the Essen/Düsseldorf partner location of the German Cancer Consortium (DKTK), was voted onto the…

17/11/2016

Dr Stefan Kaufmann MP visits German Cancer Research Center

08/11/2016

DKTK Berlin: Boost for cancer therapies with tumors grown in petri-dish

2.6 Million Euros for the Charité Berlin Cancer can be caused by a variety of genetic mutations. One challenge medicine faces is finding tailor-made treatment for each patient based on their…